120 related articles for article (PubMed ID: 17529996)
1. Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection.
de Fabritiis P; Spagnoli A; Di Bartolomeo P; Locasciulli A; Cudillo L; Milone G; Busca A; Picardi A; Scimè R; Bonini A; Cupelli L; Chiusolo P; Olivieri A; Santarone S; Poidomani M; Fallani S; Novelli A; Majolino I
Bone Marrow Transplant; 2007 Aug; 40(3):245-9. PubMed ID: 17529996
[TBL] [Abstract][Full Text] [Related]
2. Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.
Candoni A; Mestroni R; Damiani D; Tiribelli M; Michelutti A; Silvestri F; Castelli M; Viale P; Fanin R
Eur J Haematol; 2005 Sep; 75(3):227-33. PubMed ID: 16104879
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients.
Chou LS; Lewis RE; Ippoliti C; Champlin RE; Kontoyiannis DP
Pharmacotherapy; 2007 Dec; 27(12):1644-50. PubMed ID: 18041885
[TBL] [Abstract][Full Text] [Related]
4. Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection.
Tissot F; Pascual M; Hullin R; Yerly P; Tozzi P; Meylan P; Manuel O
Transplantation; 2014 Jun; 97(11):1192-7. PubMed ID: 24521774
[TBL] [Abstract][Full Text] [Related]
5. An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality.
Dignan FL; Evans SO; Ethell ME; Shaw BE; Davies FE; Dearden CE; Treleaven JG; Riley UB; Morgan GJ; Potter MN
Bone Marrow Transplant; 2009 Jul; 44(1):51-6. PubMed ID: 19139735
[TBL] [Abstract][Full Text] [Related]
6. Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.
Krüger WH; Rüssmann B; de Wit M; Kröger N; Renges H; Sobottka I; Zander AR
Acta Haematol; 2005; 113(2):104-8. PubMed ID: 15802888
[TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system.
Perrella A; Esposito C; Amato G; Perrella O; Migliaccio C; Pisaniello D; Calise F; Cuomo O; Santaniello W
Infect Dis (Lond); 2016 Feb; 48(2):161-6. PubMed ID: 26513601
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years.
Shi JM; Pei XY; Luo Y; Tan YM; Tie RX; He JS; Zheng WY; Zhang J; Cai Z; Lin MF; Huang H
J Zhejiang Univ Sci B; 2015 Sep; 16(9):796-804. PubMed ID: 26365122
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients.
Liu F; Wu T; Wang JB; Cao XY; Yin YM; Zhao YL; Lu DP
Transpl Infect Dis; 2013 Jun; 15(3):243-50. PubMed ID: 23496156
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of caspofungin in prophylaxis and treatment of an adult leukemic patient with invasive pulmonary aspergillosis in allogeneic stem cell transplantation.
Ifran A; Kaptan K; Beyan C
Mycoses; 2005 Mar; 48(2):146-8. PubMed ID: 15743435
[TBL] [Abstract][Full Text] [Related]
11. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
12. A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).
Cattaneo C; Monte S; Algarotti A; Audisio E; Borlenghi E; Campiotti L; Cerqui E; Fanizza C; Giuliani R; Micò C; Rocconi R; Salvi A; Salvi F; Verga L; Levis A; Lambertenghi Deliliers G; Pogliani EM; Tognoni G; Rambaldi A; Rossi G
J Antimicrob Chemother; 2011 Sep; 66(9):2140-5. PubMed ID: 21729932
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and outcomes of invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients in the era of antifungal prophylaxis: a single-centre study with focus on emerging pathogens.
Corzo-León DE; Satlin MJ; Soave R; Shore TB; Schuetz AN; Jacobs SE; Walsh TJ
Mycoses; 2015 Jun; 58(6):325-36. PubMed ID: 25808822
[TBL] [Abstract][Full Text] [Related]
14. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.
Auberger J; Lass-Flörl C; Ulmer H; Nogler-Semenitz E; Clausen J; Gunsilius E; Einsele H; Gastl G; Nachbaur D
Int J Hematol; 2008 Dec; 88(5):508-515. PubMed ID: 18982251
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin as second-line therapy for fever of unknown origin or invasive fungal infection following allogeneic stem cell transplantation.
Trenschel R; Ditschkowski M; Elmaagacli AH; Koldehoff M; Ottinger H; Steckel N; Hlinka M; Peceny R; Rath PM; Dermoumi H; Beelen DW
Bone Marrow Transplant; 2005 Mar; 35(6):583-6. PubMed ID: 15756283
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Mariotti J; De Philippis C; Bramanti S; Sarina B; Tordato F; Pocaterra D; Casari E; Carlo-Stella C; Santoro A; Castagna L
Eur J Haematol; 2019 Apr; 102(4):357-367. PubMed ID: 30672611
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients.
Cesaro S; Giacchino M; Locatelli F; Spiller M; Buldini B; Castellini C; Caselli D; Giraldi E; Tucci F; Tridello G; Rossi MR; Castagnola E
BMC Infect Dis; 2007 Apr; 7():28. PubMed ID: 17442100
[TBL] [Abstract][Full Text] [Related]
18. Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies.
Mattiuzzi GN; Alvarado G; Giles FJ; Ostrosky-Zeichner L; Cortes J; O'brien S; Verstovsek S; Faderl S; Zhou X; Raad II; Bekele BN; Leitz GJ; Lopez-Roman I; Estey EH
Antimicrob Agents Chemother; 2006 Jan; 50(1):143-7. PubMed ID: 16377679
[TBL] [Abstract][Full Text] [Related]
19. Safety profile of concomitant use of caspofungin and cyclosporine or tacrolimus in liver transplant patients.
Saner F; Gensicke J; Rath P; Fruhauf N; Gu Y; Paul A; Radtke A; Malagó M; Broelsch C
Infection; 2006 Dec; 34(6):328-32. PubMed ID: 17180587
[TBL] [Abstract][Full Text] [Related]
20. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
van de Sande WW; van Vianen W; ten Kate MT; Vissers J; Laurijsens J; Tavakol M; Rijnders BJ; Mathot RA; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2008 Apr; 52(4):1345-50. PubMed ID: 18195059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
